ClinicalTrials.gg
Enrolling by invitationNCT07658547NUKI-PSYUpdated Nov 16, 2026

Use of AI Chatbots for Mental Health

An observational study in Severe Mental Illness, sponsored by Medizinische Hochschule Brandenburg Theodor Fontane. Enrolling by invitation at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by Medizinische Hochschule Brandenburg Theodor Fontane · Observational

How we know

Updated Nov 16, 2026Primary completion movedStudy completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
150
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this observational study is to learn how patients with mental disorders use, perceive, and evaluate generative artificial intelligence (AI) chatbots for mental health-related purposes. The study aims to investigate usage patterns, expectations, experiences, perceived benefits, barriers, and concerns regarding AI chatbots among adults receiving psychiatric or psychotherapeutic treatment.

The main questions it aims to answer are:

  • "How do patients with mental disorders use generative AI chatbots in the context of their mental health?"
  • "What expectations, attitudes, and experiences do patients have regarding AI chatbots for mental health support?"

Participants will:

  • Provide electronic informed consent before participation.
  • Complete a one-time anonymous online survey lasting approximately 8 to 10 minutes.
  • Answer questions about sociodemographic characteristics, psychiatric diagnoses, psychological distress, and digital device use.
  • Report their expectations regarding AI chatbots for mental health support.
  • Provide information about AI chatbot use, including frequency, duration, applications used, and purposes of use.
  • Answer questions regarding satisfaction, trust, privacy concerns, perceived problems, and potential future integration of AI chatbots into mental health care.
  • Optionally provide qualitative comments and suggestions in open-text fields.
  • Optionally participate in semi-structured qualitative interviews to explore their experiences, attitudes, and perceptions regarding AI chatbots in greater depth.

There is no intervention, randomization, control group, or comparison arm in this study. The study follows a prospective cross-sectional mixed-methods design using quantitative survey data, qualitative free-text responses, and semi-structured interviews.

02

Conditions studied

  • Severe Mental Illness

Browse trials for

03

In context

Mental Disorders

1,746 studies on the registry are indexed under Mental Disorders; 350 are open to participants now.

This study's planned enrollment of 150 is below the median of 220 across 391 observational studies indexed under Mental Disorders.

Browse Mental Disorders studies →

Lead sponsor

Medizinische Hochschule Brandenburg Theodor Fontane is the lead sponsor of 17 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Psychiatric outpatient clinics, medical practices, and counseling centers in Berlin/Brandenburg

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • diagnosed mental illness

Exclusion criteria

Exclusion Criteria:

  • incapable of giving consent
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
150 participants (estimated)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • Severe Mental Illness
06

What researchers measure

Primary outcomes

  1. Percentage of patients who have used generative AI for mental health issues

    Time frame: up to 6 months

07

Study locations

1 site
08

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Started Jul 2026 (actual). Primary completion is estimated for Dec 2026, 5 months after the start.

Start moved once since we started tracking on Sep 25, 2026: Jun 2026 → Jul 2026, on Oct 8, 2026.

Primary completion moved twice since we started tracking on Sep 25, 2026: Aug 2026 → Dec 2026, last on Nov 16, 2026.

Completion moved once since we started tracking on Sep 25, 2026: Nov 2026 → Dec 2026, on Nov 16, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jun 8, 2026
First posted
Jun 22, 2026
StartActual
Jul 31, 2026was Jun 2026
Primary completionEst.
Dec 2026was Aug 2026
CompletionEst.
Dec 2026was Nov 2026
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Jun 2026→Jul 31, 2026 (actual)
Oct 8, 2026
Primary completion
Aug 2026→Dec 2026
moved 2 times, Oct 8, 2026 – Nov 16, 2026
Study completion
Nov 2026→Dec 2026
Nov 16, 2026
Show all 2 updates
  1. Nov 16, 2026
    Primary completion Oct 2026→Dec 2026
    Study completion Nov 2026→Dec 2026
  2. Oct 8, 2026
    Start date Jun 2026→Jul 31, 2026 (now actual)
    Primary completion Aug 2026→Oct 2026
    + 2 other changes: verification date and description

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07658547
Lead sponsor
Medizinische Hochschule Brandenburg Theodor Fontane
Responsible party
Julian Schwarz (Head of Mental Health Policy & Digitalization Research Group, Medizinische Hochschule Brandenburg Theodor Fontane) — Principal investigator
First posted
Jun 22, 2026
Start date
Jul 31, 2026
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Nov 16, 2026

Study contacts

Schwarz
principal investigator · Medizinische Hochschule Brandenburg Theodor Fontane
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion